These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12423001)

  • 21. Beating the system: a study of a creatinine assay and its efficacy in authenticating human urine specimens.
    Villena VP
    J Anal Toxicol; 2010; 34(1):39-44. PubMed ID: 20109301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 23. A field evaluation of five on-site drug-testing devices.
    Crouch DJ; Hersch RK; Cook RF; Frank JF; Walsh JM
    J Anal Toxicol; 2002 Oct; 26(7):493-9. PubMed ID: 12423006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of lowering the screening and confirmation cutoff values for urine drug testing based on dilution indicators.
    Fraser AD; Zamecnik J
    Ther Drug Monit; 2003 Dec; 25(6):723-7. PubMed ID: 14639059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of chromate adulteration of human urine by automated colorimetric and capillary ion electrophoretic analyses.
    Ferslew KE; Nicolaides AN; Robert TA
    J Anal Toxicol; 2003; 27(1):36-9. PubMed ID: 12587681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the OnTrak Testcup-5 to laboratory urinalysis among arrestees.
    Yacoubian GS; Wish ED; Choyka JD
    J Psychoactive Drugs; 2002; 34(3):325-9. PubMed ID: 12422945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transformation of codeine and codeine-6-glucuronide to opioid analogues by urine adulteration with pyridinium chlorochromate: potential issue for urine drug testing.
    Luong S; Ung AT; Kalman J; Fu S
    Rapid Commun Mass Spectrom; 2014 Jul; 28(14):1609-20. PubMed ID: 24895258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrophotometric detection of iodide and chromic (III) in urine after oxidation to iodine and chromate (VI).
    Paul BD; Jacobs A
    J Anal Toxicol; 2005 Oct; 29(7):658-63. PubMed ID: 16419396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups.
    Lin CN; Nelson GJ; McMillin GA
    J Anal Toxicol; 2013; 37(1):30-6. PubMed ID: 23144203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of morphine and codeine in samples adulterated with Stealth.
    Cody JT; Valtier S; Kuhlman J
    J Anal Toxicol; 2001 Oct; 25(7):572-5. PubMed ID: 11599602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrite adulteration of workplace urine drug-testing specimens. I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration.
    Urry FM; Komaromy-Hiller G; Staley B; Crockett DK; Kushnir M; Nelson G; Struempler RE
    J Anal Toxicol; 1998; 22(2):89-95. PubMed ID: 9547404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.